S&S Investment
VC Fund
Bundangdong, South Korea
S&S Investment is a VC fund in Bundangdong focused on Artificial Intelligence and Therapeutics. Venture Capital
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries S&S Investment invests in
Stages S&S Investment invests in
Countries S&S Investment invests in
Investment Focus
Industry
- Artificial Intelligence 3 (30%)
- Therapeutics 2 (20%)
- News 1 (10%)
- EdTech 1 (10%)
- Energy 1 (10%)
Stage
- Series A 3 (30%)
- Series B 3 (30%)
- Seed 1 (10%)
- Series C 1 (10%)
- Funding Round 1 (10%)
Country
- South Korea 6 (60%)
- United States 2 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Buysell Standards
|
Buysell Standards is the provider of manpower supply and employment arrangement services. | $3.4M / Series A / Mar 11, 2026 | |
Playtag
|
Playtag operates an AI-based platform that uses behavioral analytics for early childhood education. The company develops learning tools for infants and toddlers and provides systems for kindergartens and daycare centers. These systems support the use of data-driven methods in teaching and classroom activities. | $4.4M / Venture - Series Unknown / Nov 25, 2025 | |
Crocus Energy
|
Crocus Energy is a software company that utilizes artificial intelligence to enhance transparency in electricity consumption within large, energy-intensive facilities. This approach offers valuable insights and clarity regarding the consequences of each decision made. Additionally, the company manages the fast charging system for electric vehiclesknown as 'Acello EV' and the power optimization control solution referred to as 'Acello GRID'. | $11.7M / Series C / Nov 18, 2025 | |
PineTree Therapeutics
|
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $47M / Series B / Oct 28, 2025 | |
Illimis Therapeutics
|
Illimis Therapeutics is a platform-based biotech company that develops a chimeric fusion protein platform for neurodegenerative diseases. The company's proprietary GAIA (Gas6-mediated Anti-Inflammatory Adaptor) platform is designed to harness the therapeutic potential of TAM (Tyro3, Axl, Mer) receptor biology, a critical pathway involved inregulating inflammation and immune responses. | $41.9M / Series B / Jul 14, 2025 | |
Purience
|
Purience is a semiconductor materials company developing PVA brushes and AI-based process solutions for chip manufacturing. It focuses on supplying advanced materials and equipment used in semiconductor cleaning and process optimization. The company supports semiconductor production through material innovation and technology-driven solutions formanufacturing processes. | $2.5M / Seed / Feb 28, 2025 | |
|
PineTree Therapeutics
|
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $17M / Series A / Jul 30, 2024 | |
Dot Mill
|
Dot Mill is a media and entertainment technology company that designs, produces, and operates digital theme parks, interactive exhibitions, media attractions, and XR-based experiences. Dotmill combines storytelling with projection mapping, holograms, interactive media, digital twins, and extended reality technologies to create highly immersivevisitor experiences. | $11.7M / Sep 01, 2023 | |
|
Crocus Energy
|
Crocus Energy is a software company that utilizes artificial intelligence to enhance transparency in electricity consumption within large, energy-intensive facilities. This approach offers valuable insights and clarity regarding the consequences of each decision made. Additionally, the company manages the fast charging system for electric vehiclesknown as 'Acello EV' and the power optimization control solution referred to as 'Acello GRID'. | $5M / Series B / Mar 23, 2023 | |
Boosters
|
Boosters is a brand aggregator that uncovers and acquires high-potential brands that have been hidden for a long time, or discovers commerce businesses that will be appreciated by the public at an early stage. They achieve scale-up by developing tactics that are specific to each brand's attributes. Scale-up is the maximum of sales forBoosters. | $10M / Series A / Jan 26, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does S&S Investment invest in?
S&S Investment invests primarily in Artificial Intelligence, Therapeutics and News startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did S&S Investment last invest?
The most recent investment recorded for S&S Investment closed in Mar 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
